5,7-Dihydrothieno<3,4-b>pyrazin | 35162-55-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5,7-Dihydrothieno<3,4-b>pyrazin
• 英文别名: 5,7-Dihydrothieno[3,4-b]pyrazine
• CAS: 35162-55-1
• 化学式: C₆H₆N₂S
• 分子量: 138.193
• InChiKey: SQMDMAFCPGEDER-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  51.1
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE
  申请人：SUMITOMO DAINIPPON PHARMA CO., LTD.

  公开号：US20210387967A1

  公开（公告）日：2021-12-16

  Provided is a 2-heteroaryl aminoquinazolinone derivative, which is a compound represented by formula (1): or a pharmaceutically acceptable salt thereof wherein X 1 represents CR 1 or N, X 2 represents CR 2 or N, X 3 represents CR 3 or N, X 4 represents CR 4 or N, Y represents optionally substituted C 1-6 alkyl, an optionally substituted C 3-10 alicyclic group, an optionally substituted 4- to 10-membered nitrogen-containing non-aryl heterocycle, optionally substituted C 6-10 aryl, or optionally substituted 5- to 10-membered heteroaryl, Z represents optionally substituted 6- to 10-membered heteroaryl, and R 1 , R 2 , R 3 , and R 4 each independently represent a hydrogen atom, halogen, cyano, optionally substituted C 1-6 alkyl, optionally substituted C 1-6 alkoxy, or the like.

  提供了一种2-杂环芳基氨基喹唑啉酮衍生物，该化合物由式（1）表示：或其药学上可接受的盐其中X1代表CR1或N，X2代表CR2或N，X3代表CR3或N，X4代表CR4或N，Y代表可选择取代的C1-6烷基，可选择取代的C3-10脂环基，可选择取代的含氮非芳基杂环的4-至10-成员环，可选择取代的C6-10芳基，或可选择取代的5-至10-成员杂环芳基，Z代表可选择取代的6-至10-成员杂环芳基，R1、R2、R3和R4各自独立地代表氢原子、卤素、氰基、可选择取代的C1-6烷基、可选择取代的C1-6甲氧基等。
• 2-AMINOQUINAZOLINONE DERIVATIVE
  申请人：SUMITOMO DAINIPPON PHARMA CO., LTD.

  公开号：US20210380598A1

  公开（公告）日：2021-12-09

  The present invention provides a 2-aminoquinazolinone derivative. The present invention is a compound represented by formula (1) [wherein X 1 represents CR or N, X 2 represents CR 2 or N, X 3 represents CR 3 or N, Y represents an optionally substituted C 6-10 aryl or optionally substituted 6 to 10-membered heteroaryl, Z represents an optionally substituted C 6-10 aryl, R A represents a hydrogen atom, halogen, cyano, optionally substituted C 1-6 alkyl sulfonyl, optionally substituted C 1-6 alkyl, or optionally substituted C 1-6 alkoxy, and R 1 , R 2 , and R 3 independently represent a hydrogen atom, halogen, optionally substituted C 1-6 alkyl, or optionally substituted C 1-6 alkoxy] or a pharmaceutically acceptable salt thereof.

  本发明提供了一种2-氨基喹唑啉酮衍生物。本发明是一种化合物，由式（1）表示[其中X1表示CR或N，X2表示CR2或N，X3表示CR3或N，Y表示可选取代的C6-10芳基或可选取代的6到10元杂环芳基，Z表示可选取代的C6-10芳基，RA表示氢原子，卤素，氰基，可选取代的C1-6烷基磺酰基，可选取代的C1-6烷基或可选取代的C1-6烷氧基，R1、R2和R3独立地表示氢原子，卤素，可选取代的C1-6烷基或可选取代的C1-6烷氧基]或其药学上可接受的盐。
• 2-aminoquinazolinone derivative
  申请人：SUMITOMO DAINIPPON PHARMA CO., LTD.

  公开号：US11352366B2

  公开（公告）日：2022-06-07

  The present invention provides a 2-aminoquinazolinone derivative. The present invention is a compound represented by formula (1) [wherein X1 represents CR or N, X2 represents CR2 or N, X3 represents CR3 or N, Y represents an optionally substituted C6-10 aryl or optionally substituted 6 to 10-membered heteroaryl, Z represents an optionally substituted C6-10 aryl, RA represents a hydrogen atom, halogen, cyano, optionally substituted C1-6 alkyl sulfonyl, optionally substituted C1-6 alkyl, or optionally substituted C1-6 alkoxy, and R1, R2, and R3 independently represent a hydrogen atom, halogen, optionally substituted C1-6 alkyl, or optionally substituted C1-6 alkoxy] or a pharmaceutically acceptable salt thereof.

  本发明提供了一种2-氨基喹唑啉酮衍生物。本发明是一种由式（1）表示的化合物 [其中 X1 代表 CR 或 N，X2 代表 CR2 或 N，X3 代表 CR3 或 N，Y 代表任选取代的 C6-10 芳基或任选取代的 6 至 10 元杂芳基，Z 代表任选取代的 C6-10 芳基，RA 代表氢原子、卤素、氰基、任选取代的 C1-6 烷基磺酰基、任选取代的 C1-6 烷基或任选取代的 C1-6 烷氧基，且 R1、R2 和 R3 独立地代表氢原子、卤素、任选取代的 C1-6 烷基或任选取代的 C1-6 烷氧基]或其药学上可接受的盐。
• Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
  申请人：Inflazome Limited

  公开号：US11370776B2

  公开（公告）日：2022-06-28

  The present invention relates to compounds of formula (I): wherein Q is O or S, R1 is a 6-membered heteroaryl group containing at least one nitrogen atom in the 6-membered ring structure, wherein R1 may optionally be substituted, and R2 is a cyclic group substituted at the α-position, wherein R2 may optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the inhibition of NLRP3.

  本发明涉及式（I）化合物： 其中 Q 是 O 或 S，R1 是在 6 元环结构中含有至少一个氮原子的 6 元杂芳基，其中 R1 可任选被取代，R2 是在α 位被取代的环状基团，其中 R2 可任选被进一步取代。本发明进一步涉及此类化合物的盐、溶液剂和原药，涉及包含此类化合物的药物组合物，涉及此类化合物在治疗和预防医学紊乱和疾病中的用途，特别是通过抑制 NLRP3。
• SOLID ELECTROLYTIC CAPACITOR AND PROCESS FOR THE PRODUCTION THEREOF
  申请人：Showa Denko K K

  公开号：EP0971382B1

  公开（公告）日：2009-04-22